Literature DB >> 1610121

Incontinentia pigmenti (type 1) and X;5 translocation.

P Bitoun1, C Philippe, M Cherif, M T Mulcahy, S Gilgenkrantz.   

Abstract

The authors present a 5-year-old girl with total absence of speech, dysmorphic features, pigmented lesions on the legs, an abnormal EEG and otherwise normal intelligence representing a mild form of type 1 Incontinentia pigmenti associated with an (X;5) (p11.2;q35.2) apparently balanced translocation prenatally diagnosed. The seven previous translocation type 1 IP patients are reviewed and all have the same Xp11 breakpoint. Somatic cell hybrids have been made to further study this breakpoint and further define the putative type 1 IP gene.

Entities:  

Mesh:

Year:  1992        PMID: 1610121

Source DB:  PubMed          Journal:  Ann Genet        ISSN: 0003-3995


  4 in total

1.  X inactivation analysis in a female with hypomelanosis of Ito associated with a balanced X;17 translocation: evidence for functional disomy of Xp.

Authors:  E Hatchwell; D Robinson; J A Crolla; A E Cockwell
Journal:  J Med Genet       Date:  1996-03       Impact factor: 6.318

Review 2.  Mendelian cytogenetics. Chromosome rearrangements associated with mendelian disorders.

Authors:  N Tommerup
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

Review 3.  Incontinentia pigmenti nomenclature.

Authors:  V P Sybert
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

4.  Complex nature of apparently balanced chromosomal rearrangements in patients with autism spectrum disorder.

Authors:  Anne-Claude Tabet; Alain Verloes; Marion Pilorge; Elsa Delaby; Richard Delorme; Gudrun Nygren; Françoise Devillard; Marion Gérard; Sandrine Passemard; Delphine Héron; Jean-Pierre Siffroi; Aurelia Jacquette; Andrée Delahaye; Laurence Perrin; Céline Dupont; Azzedine Aboura; Pierre Bitoun; Mary Coleman; Marion Leboyer; Christopher Gillberg; Brigitte Benzacken; Catalina Betancur
Journal:  Mol Autism       Date:  2015-03-25       Impact factor: 7.509

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.